Skip to main content
Top
Published in: European Radiology 11/2016

01-11-2016 | Chest

Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen

Authors: Nicola Sverzellati, M. Silva, G. Calareso, C. Galeone, A. Marchianò, S. Sestini, G. Sozzi, U. Pastorino

Published in: European Radiology | Issue 11/2016

Login to get access

Abstract

Objectives

To compare the performance metrics of two different strategies of lung cancer screening by low-dose computed tomography (LDCT), namely, annual (LDCT1) or biennial (LDCT2) screen.

Methods

Recall rate, detection rate, interval cancers, sensitivity, specificity, positive and negative predictive values (PPV and NPV, respectively) were compared between LDCT1 and LDCT2 arms of the MILD trial over the first seven (T0-T6; median follow-up 7.3 years) and four rounds (T0-T3; median follow-up 7.3 years), respectively.

Results

1152 LDCT1 and 1151 LDCT2 participants underwent a total of 6893 and 4715 LDCT scans, respectively. The overall recall rate was higher in LDCT2 arm (6.97 %) than in LDCT1 arm (5.81 %) (p = 0.01), which was counterbalanced by the overall lower number of LDCT scans. No difference was observed for the overall detection rate (0.56 % in both arms). The two LDCT arms had similar specificity (99.2 % in both arms), sensitivity (73.5 %, in LDCT2 vs. 68.5 % in LDCT1, p = 0.62), PPV (42.4 %, in LDCT2, vs. 40.6 %, in LDCT1, p = 0.83) and NPV (99.8 %, in LDCT2 vs. 99.7 %, in LDCT1, p = 0.71).

Conclusion

Biennial screen may save about one third of LDCT scans with similar performance indicators as compared to annual screening.

Key Points

Biennial LDCT screening may be as efficient as the annual screening.
Annual and biennial LDCT screening have similar frequency of interval lung cancers.
Biennial screening may save about one third of LDCT scans.
Appendix
Available only for authorised users
Literature
1.
go back to reference Saghir Z, Dirksen A, Ashraf H et al (2012) CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 67:296–301CrossRefPubMed Saghir Z, Dirksen A, Ashraf H et al (2012) CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 67:296–301CrossRefPubMed
2.
go back to reference Pastorino U, Rossi M, Rosato V et al (2012) Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 21:308–315CrossRefPubMed Pastorino U, Rossi M, Rosato V et al (2012) Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 21:308–315CrossRefPubMed
3.
go back to reference National Lung Screening Trial Research T, Aberle DR, Adams AM et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409CrossRef National Lung Screening Trial Research T, Aberle DR, Adams AM et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409CrossRef
4.
go back to reference Infante M, Cavuto S, Lutman FR, et al (2015) Long-term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. Am J Respir Crit Care Med Infante M, Cavuto S, Lutman FR, et al (2015) Long-term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. Am J Respir Crit Care Med
5.
go back to reference Heuvelmans MA, Vliegenthart R, Oudkerk M (2015) Contributions of the European trials (European randomized screening group) in computed tomography lung cancer screening. J Thorac Imaging 30:101–107CrossRefPubMed Heuvelmans MA, Vliegenthart R, Oudkerk M (2015) Contributions of the European trials (European randomized screening group) in computed tomography lung cancer screening. J Thorac Imaging 30:101–107CrossRefPubMed
6.
go back to reference Field JK, Hansell DM, Duffy SW, Baldwin DR (2013) CT screening for lung cancer: countdown to implementation. Lancet Oncol 14:e591–e600CrossRefPubMed Field JK, Hansell DM, Duffy SW, Baldwin DR (2013) CT screening for lung cancer: countdown to implementation. Lancet Oncol 14:e591–e600CrossRefPubMed
7.
go back to reference Moyer VA, Force USPST (2014) Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 160:330–338PubMed Moyer VA, Force USPST (2014) Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 160:330–338PubMed
9.
go back to reference de Koning HJ, Meza R, Plevritis SK et al (2014) Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 160:311–320CrossRefPubMedPubMedCentral de Koning HJ, Meza R, Plevritis SK et al (2014) Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 160:311–320CrossRefPubMedPubMedCentral
10.
go back to reference Marchiano A, Calabro E, Civelli E et al (2009) Pulmonary nodules: volume repeatability at multidetector CT lung cancer screening. Radiology 251:919–925CrossRefPubMed Marchiano A, Calabro E, Civelli E et al (2009) Pulmonary nodules: volume repeatability at multidetector CT lung cancer screening. Radiology 251:919–925CrossRefPubMed
11.
go back to reference Horeweg N, Scholten ET, de Jong PA et al (2014) Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 15:1342–1350CrossRefPubMed Horeweg N, Scholten ET, de Jong PA et al (2014) Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 15:1342–1350CrossRefPubMed
12.
go back to reference Goldstraw P, Crowley J, Chansky K et al (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2:706–714CrossRefPubMed Goldstraw P, Crowley J, Chansky K et al (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2:706–714CrossRefPubMed
13.
go back to reference Seigneurin A, Field JK, Gachet A, Duffy SW (2014) A systematic review of the characteristics associated with recall rates, detection rates and positive predictive values of computed tomography screening for lung cancer. Ann Oncol 25:781–791CrossRefPubMed Seigneurin A, Field JK, Gachet A, Duffy SW (2014) A systematic review of the characteristics associated with recall rates, detection rates and positive predictive values of computed tomography screening for lung cancer. Ann Oncol 25:781–791CrossRefPubMed
14.
go back to reference National Lung Screening Trial Research T, Church TR, Black WC et al (2013) Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 368:1980–1991CrossRef National Lung Screening Trial Research T, Church TR, Black WC et al (2013) Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 368:1980–1991CrossRef
15.
16.
go back to reference Becker N, Motsch E, Gross ML et al (2012) Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol 138:1475–1486CrossRefPubMed Becker N, Motsch E, Gross ML et al (2012) Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol 138:1475–1486CrossRefPubMed
17.
go back to reference Field JK, van Klaveren R, Pedersen JH et al (2013) European randomized lung cancer screening trials: Post NLST. J Surg Oncol 108:280–286CrossRefPubMed Field JK, van Klaveren R, Pedersen JH et al (2013) European randomized lung cancer screening trials: Post NLST. J Surg Oncol 108:280–286CrossRefPubMed
18.
go back to reference Becker N, Motsch E, Gross ML, et al. (2015) Randomised study on early detection of lung cancer with MSCT in Germany: results of the first 3 years of follow-up after randomisation. J Thorac Oncol Becker N, Motsch E, Gross ML, et al. (2015) Randomised study on early detection of lung cancer with MSCT in Germany: results of the first 3 years of follow-up after randomisation. J Thorac Oncol
Metadata
Title
Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen
Authors
Nicola Sverzellati
M. Silva
G. Calareso
C. Galeone
A. Marchianò
S. Sestini
G. Sozzi
U. Pastorino
Publication date
01-11-2016
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 11/2016
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-016-4228-3

Other articles of this Issue 11/2016

European Radiology 11/2016 Go to the issue